[
  {
    "ts": "2025-11-12T00:52:08+00:00",
    "headline": "Dow Jones Hits Record Close With Palantir, Eli Lilly In Buy Areas; These AI Stocks Tumble",
    "summary": "The Dow Jones hit a closing high while the broader market held recent gains. Palantir and Eli Lilly are in buy zones. AI computing stocks CoreWeave and Nebius sold off.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-record-close-palantir-eli-lilly-buy-areas-ai-stocks-nebius-coreweave/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "8d21bfae-8d30-35a6-bbbf-47af4a069558",
      "content": {
        "id": "8d21bfae-8d30-35a6-bbbf-47af4a069558",
        "contentType": "STORY",
        "title": "Dow Jones Hits Record Close With Palantir, Eli Lilly In Buy Areas; These AI Stocks Tumble",
        "description": "",
        "summary": "The Dow Jones hit a closing high while the broader market held recent gains. Palantir and Eli Lilly are in buy zones. AI computing stocks CoreWeave and Nebius sold off.",
        "pubDate": "2025-11-12T00:52:08Z",
        "displayTime": "2025-11-12T00:52:08Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/8d21bfae-8d30-35a6-bbbf-47af4a069558/dow-jones-hits-record-close.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/06adc6edfd81c3c12fdd7d6e4df299f4",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KQwF6nOSFx96MD.ZYmuO2w--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/06adc6edfd81c3c12fdd7d6e4df299f4.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xGrRNYsAI8PyVSW3Vr0l0A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/06adc6edfd81c3c12fdd7d6e4df299f4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-record-close-palantir-eli-lilly-buy-areas-ai-stocks-nebius-coreweave/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "DB"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "OKLO"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "NBIS"
            },
            {
              "symbol": "ZS"
            },
            {
              "symbol": "MPC"
            },
            {
              "symbol": "GE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T03:03:28+00:00",
    "headline": "Dow Jones Futures Rise After Dow Hits Record Close; Palantir, Eli Lilly In Buy Areas",
    "summary": "The Dow Jones hit a closing high while the broader market held recent gains. Palantir and Eli Lilly are in buy zones. AI computing stocks CoreWeave and Nebius sold off.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-record-close-palantir-eli-lilly-buy-areas-ai-stocks-nebius-coreweave/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "8d21bfae-8d30-35a6-bbbf-47af4a069558",
      "content": {
        "id": "8d21bfae-8d30-35a6-bbbf-47af4a069558",
        "contentType": "STORY",
        "title": "Dow Jones Futures Rise After Dow Hits Record Close; Palantir, Eli Lilly In Buy Areas",
        "description": "",
        "summary": "The Dow Jones hit a closing high while the broader market held recent gains. Palantir and Eli Lilly are in buy zones. AI computing stocks CoreWeave and Nebius sold off.",
        "pubDate": "2025-11-12T03:03:28Z",
        "displayTime": "2025-11-12T03:03:28Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/8d21bfae-8d30-35a6-bbbf-47af4a069558/dow-jones-futures-rise-after.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/06adc6edfd81c3c12fdd7d6e4df299f4",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KQwF6nOSFx96MD.ZYmuO2w--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/06adc6edfd81c3c12fdd7d6e4df299f4.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xGrRNYsAI8PyVSW3Vr0l0A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/06adc6edfd81c3c12fdd7d6e4df299f4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-record-close-palantir-eli-lilly-buy-areas-ai-stocks-nebius-coreweave/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MPC"
            },
            {
              "symbol": "ZS"
            },
            {
              "symbol": "GE"
            },
            {
              "symbol": "OKLO"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "NBIS"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "DB"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T03:55:39+00:00",
    "headline": "Dow Jones Futures Rise After Dow's Record Close; Palantir, Eli Lilly In Buy Areas",
    "summary": "The Dow Jones hit a closing high while the broader market held recent gains. Palantir and Eli Lilly are in buy zones. AI computing stocks CoreWeave and Nebius sold off.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-record-close-palantir-eli-lilly-buy-areas-ai-stocks-nebius-coreweave/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "8d21bfae-8d30-35a6-bbbf-47af4a069558",
      "content": {
        "id": "8d21bfae-8d30-35a6-bbbf-47af4a069558",
        "contentType": "STORY",
        "title": "Dow Jones Futures Rise After Dow's Record Close; Palantir, Eli Lilly In Buy Areas",
        "description": "",
        "summary": "The Dow Jones hit a closing high while the broader market held recent gains. Palantir and Eli Lilly are in buy zones. AI computing stocks CoreWeave and Nebius sold off.",
        "pubDate": "2025-11-12T03:55:39Z",
        "displayTime": "2025-11-12T03:55:39Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/8d21bfae-8d30-35a6-bbbf-47af4a069558/dow-jones-futures-rise-after.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/06adc6edfd81c3c12fdd7d6e4df299f4",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KQwF6nOSFx96MD.ZYmuO2w--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/06adc6edfd81c3c12fdd7d6e4df299f4.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xGrRNYsAI8PyVSW3Vr0l0A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/06adc6edfd81c3c12fdd7d6e4df299f4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-record-close-palantir-eli-lilly-buy-areas-ai-stocks-nebius-coreweave/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "DB"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "OKLO"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "ZS"
            },
            {
              "symbol": "NBIS"
            },
            {
              "symbol": "MPC"
            },
            {
              "symbol": "GE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T07:11:17+00:00",
    "headline": "Can Lilly's (LLY) Latest RNAi Deal Hint at a New Edge in Metabolic Therapies?",
    "summary": "SanegeneBio announced a global research and licensing collaboration with Eli Lilly to develop RNA interference therapies for metabolic diseases, leveraging SanegeneBio's LEAD™ platform for advanced, targeted delivery of RNAi drug candidates. This agreement, which includes up to US$1.2 billion in milestone and royalty payments, further strengthens Eli Lilly's pipeline in metabolic disease treatments and demonstrates the company's ongoing commitment to innovative therapies. We will now examine...",
    "url": "https://finance.yahoo.com/news/lillys-lly-latest-rnai-deal-071117890.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "7761d0ab-384a-3ff5-b726-3736fbc52054",
      "content": {
        "id": "7761d0ab-384a-3ff5-b726-3736fbc52054",
        "contentType": "STORY",
        "title": "Can Lilly's (LLY) Latest RNAi Deal Hint at a New Edge in Metabolic Therapies?",
        "description": "",
        "summary": "SanegeneBio announced a global research and licensing collaboration with Eli Lilly to develop RNA interference therapies for metabolic diseases, leveraging SanegeneBio's LEAD™ platform for advanced, targeted delivery of RNAi drug candidates. This agreement, which includes up to US$1.2 billion in milestone and royalty payments, further strengthens Eli Lilly's pipeline in metabolic disease treatments and demonstrates the company's ongoing commitment to innovative therapies. We will now examine...",
        "pubDate": "2025-11-12T07:11:17Z",
        "displayTime": "2025-11-12T07:11:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lillys-lly-latest-rnai-deal-071117890.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lillys-lly-latest-rnai-deal-071117890.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T09:22:00+00:00",
    "headline": "This Unstoppable Growth Stock Just Delivered More Good News: Time to Buy?",
    "summary": "This drugmaker's innovation engine continues to operate at full capacity.",
    "url": "https://www.fool.com/investing/2025/11/12/this-unstoppable-growth-stock-just-delivered-more/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "df6cd5dc-c386-355d-abef-8d1c353c2ec0",
      "content": {
        "id": "df6cd5dc-c386-355d-abef-8d1c353c2ec0",
        "contentType": "STORY",
        "title": "This Unstoppable Growth Stock Just Delivered More Good News: Time to Buy?",
        "description": "",
        "summary": "This drugmaker's innovation engine continues to operate at full capacity.",
        "pubDate": "2025-11-12T09:22:00Z",
        "displayTime": "2025-11-12T09:22:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/11dcfdcb2367f0544f0c4485b3abbe36",
          "originalWidth": 1400,
          "originalHeight": 934,
          "caption": "Patient self-administering an injector pen.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AdiSSJvC9SB6GEgCIj3CxQ--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/11dcfdcb2367f0544f0c4485b3abbe36.cf.webp",
              "width": 1400,
              "height": 934,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JBMQ7GwdDIgFjGMlED6UQg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/11dcfdcb2367f0544f0c4485b3abbe36.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/12/this-unstoppable-growth-stock-just-delivered-more/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/unstoppable-growth-stock-just-delivered-092200860.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T13:08:21+00:00",
    "headline": "Dow Jones Futures Rise; Palantir, Eli Lilly Lead Six Stocks In Buy Zones",
    "summary": "The Dow Jones hit a closing high Tuesday, leading an ongoing stock market bounce. Palantir and Eli Lilly are in buy zones while AI stocks CoreWeave and Nebius sold off.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-palantir-eli-lilly-buy-zones/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "8d21bfae-8d30-35a6-bbbf-47af4a069558",
      "content": {
        "id": "8d21bfae-8d30-35a6-bbbf-47af4a069558",
        "contentType": "STORY",
        "title": "Dow Jones Futures Rise; Palantir, Eli Lilly Lead Six Stocks In Buy Zones",
        "description": "",
        "summary": "The Dow Jones hit a closing high Tuesday, leading an ongoing stock market bounce. Palantir and Eli Lilly are in buy zones while AI stocks CoreWeave and Nebius sold off.",
        "pubDate": "2025-11-12T13:08:21Z",
        "displayTime": "2025-11-12T13:08:21Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/8d21bfae-8d30-35a6-bbbf-47af4a069558/dow-jones-futures-rise-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/06adc6edfd81c3c12fdd7d6e4df299f4",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KQwF6nOSFx96MD.ZYmuO2w--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/06adc6edfd81c3c12fdd7d6e4df299f4.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xGrRNYsAI8PyVSW3Vr0l0A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/06adc6edfd81c3c12fdd7d6e4df299f4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-palantir-eli-lilly-buy-zones/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "OKLO"
            },
            {
              "symbol": "NBIS"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "ZS"
            },
            {
              "symbol": "MPC"
            },
            {
              "symbol": "GE"
            },
            {
              "symbol": "DB"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T12:01:59+00:00",
    "headline": "PRIMECAP Management's Strategic Moves: Hess Corp Exit and Chevron Corp Addition",
    "summary": "Analyzing the Third Quarter 2025 13F Filing",
    "url": "https://finance.yahoo.com/news/primecap-managements-strategic-moves-hess-120159685.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "91cdad9f-4251-3f89-a299-94bd8282eb13",
      "content": {
        "id": "91cdad9f-4251-3f89-a299-94bd8282eb13",
        "contentType": "STORY",
        "title": "PRIMECAP Management's Strategic Moves: Hess Corp Exit and Chevron Corp Addition",
        "description": "",
        "summary": "Analyzing the Third Quarter 2025 13F Filing",
        "pubDate": "2025-11-12T12:01:59Z",
        "displayTime": "2025-11-12T12:01:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/a83cf686d95ecd160ddb282ec7def46b",
          "originalWidth": 1242,
          "originalHeight": 902,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DsLO152gHOOZelXsmvWzPw--~B/aD05MDI7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/a83cf686d95ecd160ddb282ec7def46b.cf.webp",
              "width": 1242,
              "height": 902,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L8E.Cyzeyb2xS54e9IOzBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a83cf686d95ecd160ddb282ec7def46b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/primecap-managements-strategic-moves-hess-120159685.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/primecap-managements-strategic-moves-hess-120159685.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVX"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "HES"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T14:31:11+00:00",
    "headline": "Infineon, Chevron, Eli Lilly & CVS: Trending Tickers",
    "summary": "Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including Infineon Technologies (IFX.DE, IFNNY) raising its revenue guidance on AI data center demand, Chevron (CVX) choosing West Texas as the site of its first AI data center project, and Eli Lilly (LLY) reportedly dropping CVS Health's (CVS) drug plan from employee coverage. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Morning Brief.",
    "url": "https://finance.yahoo.com/video/infineon-chevron-eli-lilly-cvs-143111076.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "c0e86cfd-809b-322a-8aa1-732c19a2c137",
      "content": {
        "id": "c0e86cfd-809b-322a-8aa1-732c19a2c137",
        "contentType": "VIDEO",
        "title": "Infineon, Chevron, Eli Lilly & CVS: Trending Tickers",
        "description": "<p>Morning Brief host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/julie-hyman/?.tsrc=fin-srch\">Julie Hyman</a> tracks several of the day's top trending stock tickers, including Infineon Technologies (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/IFX.DE\">IFX.DE</a>, <a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/IFNNY\">IFNNY</a>) raising its revenue guidance on AI data center demand, Chevron (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/CVX\">CVX</a>) choosing West Texas as the site of its first AI data center project, and Eli Lilly (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/LLY\">LLY</a>) reportedly dropping CVS Health's (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/CVS\">CVS</a>) drug plan from employee coverage.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/videos/series/morning-brief/\">Morning Brief</a>.</p>",
        "summary": "Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including Infineon Technologies (IFX.DE, IFNNY) raising its revenue guidance on AI data center demand, Chevron (CVX) choosing West Texas as the site of its first AI data center project, and Eli Lilly (LLY) reportedly dropping CVS Health's (CVS) drug plan from employee coverage. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Morning Brief.",
        "pubDate": "2025-11-12T14:31:11Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/2c6a2090-bfd4-11f0-bab7-df62d721ef18",
          "originalWidth": 3891,
          "originalHeight": 2191,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4oSXCaE1YObE_rqcSFp.8A--~B/aD0yMTkxO3c9Mzg5MTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/2c6a2090-bfd4-11f0-bab7-df62d721ef18.cf.webp",
              "width": 3891,
              "height": 2191,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/49BVp2k1OiGhb5pmAV4N.Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/2c6a2090-bfd4-11f0-bab7-df62d721ef18.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/infineon-chevron-eli-lilly-cvs-143111076.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/infineon-chevron-eli-lilly-cvs-143111076.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVX"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "IFNNF"
            },
            {
              "symbol": "IFNNY"
            },
            {
              "symbol": "IFX.DE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T14:19:21+00:00",
    "headline": "Citi bumps Eli Lilly stock target, sees over 50% upside potential",
    "summary": "Investing.com -- Citi hiked its price target on Eli Lilly to $1,500 from $1,250, implying a potential upside of more than 50% from current levels, pointing to accelerating expectations for the company’s oral GLP-1 drug orforglipron. The bank reiterated a Buy rating on the stock.",
    "url": "https://finance.yahoo.com/news/citi-bumps-eli-lilly-stock-141921169.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "5d04313b-6c68-307d-8c4a-d604fe901152",
      "content": {
        "id": "5d04313b-6c68-307d-8c4a-d604fe901152",
        "contentType": "STORY",
        "title": "Citi bumps Eli Lilly stock target, sees over 50% upside potential",
        "description": "",
        "summary": "Investing.com -- Citi hiked its price target on Eli Lilly to $1,500 from $1,250, implying a potential upside of more than 50% from current levels, pointing to accelerating expectations for the company’s oral GLP-1 drug orforglipron. The bank reiterated a Buy rating on the stock.",
        "pubDate": "2025-11-12T14:19:21Z",
        "displayTime": "2025-11-12T14:19:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/citi-bumps-eli-lilly-stock-141921169.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/citi-bumps-eli-lilly-stock-141921169.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T14:45:00+00:00",
    "headline": "Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock",
    "summary": "Recursion is about to go toe-to-toe with the largest healthcare company.",
    "url": "https://www.fool.com/investing/2025/11/12/forget-recursion-pharmaceuticals-this-could-be-an/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "40da271f-66be-35fc-9b81-d108965318ea",
      "content": {
        "id": "40da271f-66be-35fc-9b81-d108965318ea",
        "contentType": "STORY",
        "title": "Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock",
        "description": "",
        "summary": "Recursion is about to go toe-to-toe with the largest healthcare company.",
        "pubDate": "2025-11-12T14:45:00Z",
        "displayTime": "2025-11-12T14:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/1527833f00ceb9d0c9328bfbed0f43fe",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Person working in a data center.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/75WdNueMI2sLQv3RyMUEsQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/1527833f00ceb9d0c9328bfbed0f43fe.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3Fdeyp_wJUsk6HaSnSlTlQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/1527833f00ceb9d0c9328bfbed0f43fe.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/12/forget-recursion-pharmaceuticals-this-could-be-an/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/forget-recursion-pharmaceuticals-could-even-144500015.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RXRX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T13:34:00+00:00",
    "headline": "Can NVO's Ozempic, Wegovy Sales Improve in 2026 After a Subdued Q3?",
    "summary": "Novo Nordisk eyes a 2026 comeback as it slashes jobs, cuts U.S. semaglutide prices and focuses on expanding the reach of key drugs after a weak Q3.",
    "url": "https://finance.yahoo.com/news/nvos-ozempic-wegovy-sales-improve-133400829.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "ca4d39ca-5518-3637-9e09-d76c16c5da22",
      "content": {
        "id": "ca4d39ca-5518-3637-9e09-d76c16c5da22",
        "contentType": "STORY",
        "title": "Can NVO's Ozempic, Wegovy Sales Improve in 2026 After a Subdued Q3?",
        "description": "",
        "summary": "Novo Nordisk eyes a 2026 comeback as it slashes jobs, cuts U.S. semaglutide prices and focuses on expanding the reach of key drugs after a weak Q3.",
        "pubDate": "2025-11-12T13:34:00Z",
        "displayTime": "2025-11-12T13:34:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/08c70fc44d9b8340859581d38311e071",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JLDGQt80ARh3qkafoo9TaA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08c70fc44d9b8340859581d38311e071.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ncdWYZW_rP_HUKWXjdodfA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08c70fc44d9b8340859581d38311e071.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nvos-ozempic-wegovy-sales-improve-133400829.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nvos-ozempic-wegovy-sales-improve-133400829.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T16:42:44+00:00",
    "headline": "Eli Lilly Stock: This Trade On The Rising Stock Holds $1,415 In Profit Potential",
    "summary": "Eli Lilly's strong price action and high ratings present a bull call spread trading opportunity with large profit potential and clearly defined risk parameters.",
    "url": "https://www.investors.com/research/options/eli-lilly-stock-lly-options-bull-call-spread-pharma-drugs-investing-markets/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "6f0dea8a-65da-337e-9565-b1a5288d5b31",
      "content": {
        "id": "6f0dea8a-65da-337e-9565-b1a5288d5b31",
        "contentType": "STORY",
        "title": "Eli Lilly Stock: This Trade On The Rising Stock Holds $1,415 In Profit Potential",
        "description": "",
        "summary": "Eli Lilly's strong price action and high ratings present a bull call spread trading opportunity with large profit potential and clearly defined risk parameters.",
        "pubDate": "2025-11-12T16:42:44Z",
        "displayTime": "2025-11-12T16:42:44Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/6f0dea8a-65da-337e-9565-b1a5288d5b31/eli-lilly-stock-this-trade.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/43c8bd9d3366a15a100cb01f3f6833c3",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/38rPMsn1SIiEwSmyf20MsQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/43c8bd9d3366a15a100cb01f3f6833c3.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RsdxpCLyWL.13dhJNDnA5Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/43c8bd9d3366a15a100cb01f3f6833c3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/research/options/eli-lilly-stock-lly-options-bull-call-spread-pharma-drugs-investing-markets/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T16:18:50+00:00",
    "headline": "Novo Nordisk Cuts Wegovy Price in India as Eli Lilly's Mounjaro Leads Market",
    "summary": "Price reduction aims to regain ground in the world's most populous country.",
    "url": "https://finance.yahoo.com/news/novo-nordisk-cuts-wegovy-price-161850598.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "cb9d5ac7-7c74-3c10-a83f-4efa886ef8aa",
      "content": {
        "id": "cb9d5ac7-7c74-3c10-a83f-4efa886ef8aa",
        "contentType": "STORY",
        "title": "Novo Nordisk Cuts Wegovy Price in India as Eli Lilly's Mounjaro Leads Market",
        "description": "",
        "summary": "Price reduction aims to regain ground in the world's most populous country.",
        "pubDate": "2025-11-12T16:18:50Z",
        "displayTime": "2025-11-12T16:18:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/7e63317195f3cefdce4c30843a9d7c57",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9TzR39bxuUCR99sbuZJDMQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/7e63317195f3cefdce4c30843a9d7c57.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NjQrAqlrjUwsW.v1rUBg.Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/7e63317195f3cefdce4c30843a9d7c57.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-cuts-wegovy-price-161850598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-cuts-wegovy-price-161850598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T14:47:00+00:00",
    "headline": "Company News for Nov 12, 2025",
    "summary": "Companies in The News Are: SONY, SE, NVDA, LLY",
    "url": "https://finance.yahoo.com/news/company-news-nov-12-2025-144700702.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "27d9fd8d-6c48-3c7a-93bf-ccb643642168",
      "content": {
        "id": "27d9fd8d-6c48-3c7a-93bf-ccb643642168",
        "contentType": "STORY",
        "title": "Company News for Nov 12, 2025",
        "description": "",
        "summary": "Companies in The News Are: SONY, SE, NVDA, LLY",
        "pubDate": "2025-11-12T14:47:00Z",
        "displayTime": "2025-11-12T14:47:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/b40efcbfab527ad36d9e9706df6ddabb",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J2mTO0k9sDFhrqchJQSZhA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b40efcbfab527ad36d9e9706df6ddabb.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/P8JfujxIOE0lftRSYMc9pQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b40efcbfab527ad36d9e9706df6ddabb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/company-news-nov-12-2025-144700702.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/company-news-nov-12-2025-144700702.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "SE"
            },
            {
              "symbol": "SNEJF"
            },
            {
              "symbol": "SONY"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T18:00:00+00:00",
    "headline": "KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight",
    "summary": "The KRAS inhibitors market is expected to experience substantial growth, driven by rising cancer incidence, improved treatment access, and a robust pipeline including Olomorasib (Eli Lilly), MK-1084 (Merck/Taiho/Astex Pharmaceuticals), Divarasib (Roche), Daraxonrasib (Revoltuion Medicines), Onvansertib (Cardiff Oncology), ELI-002 (Elicio Therapeutics), and others across the 7MM. G12C is the most prevalent KRAS mutation in NSCLC, making it a key target of current therapies. Following the success",
    "url": "https://finance.yahoo.com/news/kras-inhibitors-market-witness-explosive-180000964.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "3086cf41-00cb-376c-abf4-9671c057a5f8",
      "content": {
        "id": "3086cf41-00cb-376c-abf4-9671c057a5f8",
        "contentType": "STORY",
        "title": "KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight",
        "description": "",
        "summary": "The KRAS inhibitors market is expected to experience substantial growth, driven by rising cancer incidence, improved treatment access, and a robust pipeline including Olomorasib (Eli Lilly), MK-1084 (Merck/Taiho/Astex Pharmaceuticals), Divarasib (Roche), Daraxonrasib (Revoltuion Medicines), Onvansertib (Cardiff Oncology), ELI-002 (Elicio Therapeutics), and others across the 7MM. G12C is the most prevalent KRAS mutation in NSCLC, making it a key target of current therapies. Following the success",
        "pubDate": "2025-11-12T18:00:00Z",
        "displayTime": "2025-11-12T18:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/77011be1a12431fff8ed0ec458d52eca",
          "originalWidth": 7024,
          "originalHeight": 1774,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8_Pel.4JrEZSti8jSw_yLA--~B/aD0xNzc0O3c9NzAyNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/77011be1a12431fff8ed0ec458d52eca.cf.webp",
              "width": 7024,
              "height": 1774,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/khWS6pAsOLHy.c8Lh585qw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/77011be1a12431fff8ed0ec458d52eca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/kras-inhibitors-market-witness-explosive-180000964.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/kras-inhibitors-market-witness-explosive-180000964.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ROG.SW"
            },
            {
              "symbol": "CRDF"
            },
            {
              "symbol": "ELTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T16:51:00+00:00",
    "headline": "How Much Did Skyrizi and Rinvoq Drive AbbVie's Q3 Performance?",
    "summary": "ABBV's growth engine keeps humming as Skyrizi and Rinvoq together now power more than 40% of total revenues and drive new market share gains.",
    "url": "https://finance.yahoo.com/news/much-did-skyrizi-rinvoq-drive-165100259.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "31e103ac-bcca-3227-84f4-404efc3c8a3e",
      "content": {
        "id": "31e103ac-bcca-3227-84f4-404efc3c8a3e",
        "contentType": "STORY",
        "title": "How Much Did Skyrizi and Rinvoq Drive AbbVie's Q3 Performance?",
        "description": "",
        "summary": "ABBV's growth engine keeps humming as Skyrizi and Rinvoq together now power more than 40% of total revenues and drive new market share gains.",
        "pubDate": "2025-11-12T16:51:00Z",
        "displayTime": "2025-11-12T16:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OQG3.5Wd9P9R69q2rhm9rA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pBlncPVBhEXpjxtBDlEOsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/much-did-skyrizi-rinvoq-drive-165100259.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/much-did-skyrizi-rinvoq-drive-165100259.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T19:19:00+00:00",
    "headline": "Novo Nordisk Slashes Wegovy Price in India as Obesity Drug War Escalates",
    "summary": "A 37% price cut, looming generics, and Lilly's Mounjaro surge turn India into the next $150B pharma battleground.",
    "url": "https://finance.yahoo.com/news/novo-nordisk-slashes-wegovy-price-191900643.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "3a039ed9-91df-338d-87c5-6ead20bed923",
      "content": {
        "id": "3a039ed9-91df-338d-87c5-6ead20bed923",
        "contentType": "STORY",
        "title": "Novo Nordisk Slashes Wegovy Price in India as Obesity Drug War Escalates",
        "description": "",
        "summary": "A 37% price cut, looming generics, and Lilly's Mounjaro surge turn India into the next $150B pharma battleground.",
        "pubDate": "2025-11-12T19:19:00Z",
        "displayTime": "2025-11-12T19:19:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/7e63317195f3cefdce4c30843a9d7c57",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9TzR39bxuUCR99sbuZJDMQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/7e63317195f3cefdce4c30843a9d7c57.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NjQrAqlrjUwsW.v1rUBg.Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/7e63317195f3cefdce4c30843a9d7c57.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-slashes-wegovy-price-191900643.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-slashes-wegovy-price-191900643.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T20:20:00+00:00",
    "headline": "Walt Disney and 15 More Non-AI Stocks Worth a Look",
    "summary": "Bank of America came up with 16 names that investors should consider buying. Renaissance Macro threw out a couple of sector ideas, too.",
    "url": "https://www.barrons.com/articles/disney-stock-non-ai-buy-dollar-general-amgen-lilly-49139509?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "bffb6a8b-5cb2-395a-bad9-869e5b4ac497",
      "content": {
        "id": "bffb6a8b-5cb2-395a-bad9-869e5b4ac497",
        "contentType": "STORY",
        "title": "Walt Disney and 15 More Non-AI Stocks Worth a Look",
        "description": "",
        "summary": "Bank of America came up with 16 names that investors should consider buying. Renaissance Macro threw out a couple of sector ideas, too.",
        "pubDate": "2025-11-12T20:20:00Z",
        "displayTime": "2025-11-12T20:20:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/bffb6a8b-5cb2-395a-bad9-869e5b4ac497/walt-disney-and-15-more.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/8f0cf881a0d1d9c00514930a68043cc7",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8UWbLGpgqwqCVzTT6.Fztw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/8f0cf881a0d1d9c00514930a68043cc7.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3wKR4q_QEZEa5r01OUaEZA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/8f0cf881a0d1d9c00514930a68043cc7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/disney-stock-non-ai-buy-dollar-general-amgen-lilly-49139509?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "DG"
            },
            {
              "symbol": "DIS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T20:55:46+00:00",
    "headline": "Sector Update: Health Care Stocks Rise Late Afternoon",
    "summary": "Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index gaining 1.6% and th",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-205546443.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "10d26b2f-25cf-3e17-a43c-bb1a9ad74b06",
      "content": {
        "id": "10d26b2f-25cf-3e17-a43c-bb1a9ad74b06",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Rise Late Afternoon",
        "description": "",
        "summary": "Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index gaining 1.6% and th",
        "pubDate": "2025-11-12T20:55:46Z",
        "displayTime": "2025-11-12T20:55:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-205546443.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-205546443.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "CNTA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T20:40:15+00:00",
    "headline": "Stock Market Today: Dow Up 400 Points; Eli Lilly, Barrick Mining, Goldman Break Out (Live Coverage)",
    "summary": "Stock Market Today: The Dow Jones index rose Wednesday and AMD rallied. Gold and silver stocks jammed.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-circle-crcl-oklo/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "1e1e145a-40b5-3a5e-a091-0f15de4eac9e",
      "content": {
        "id": "1e1e145a-40b5-3a5e-a091-0f15de4eac9e",
        "contentType": "STORY",
        "title": "Stock Market Today: Dow Up 400 Points; Eli Lilly, Barrick Mining, Goldman Break Out (Live Coverage)",
        "description": "",
        "summary": "Stock Market Today: The Dow Jones index rose Wednesday and AMD rallied. Gold and silver stocks jammed.",
        "pubDate": "2025-11-12T20:40:15Z",
        "displayTime": "2025-11-12T20:40:15Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/1e1e145a-40b5-3a5e-a091-0f15de4eac9e/stock-market-today-dow-up.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/5e940ed6659e7dd295eb62c89801d130",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ue0gOlyI1MhtsUpPPjZG4g--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/5e940ed6659e7dd295eb62c89801d130.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LIfTkMQWMNZfLj3oQ1IjUA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/5e940ed6659e7dd295eb62c89801d130.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-circle-crcl-oklo/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "ABX.TO"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]